Drug costs for patients with Parkinson's disease in two different European countries
Identifieur interne : 001318 ( Main/Exploration ); précédent : 001317; suivant : 001319Drug costs for patients with Parkinson's disease in two different European countries
Auteurs : C. Vossius [Norvège] ; M. Gjerstad [Norvège] ; H. Baas [Allemagne] ; J. P. Larsen [Norvège]Source :
- Acta Neurologica Scandinavica [ 0001-6314 ] ; 2006-04.
English descriptors
Abstract
Objective – To examine factors that influence drug costs in patients with Parkinson's disease (PD) and to compare the costs in two different countries. Methods – We examined drug costs among 438 patients with PD (286 from Germany and 152 from Norway) and collected information on the patients’ age, medication, disease duration, and Hoehn & Yahr stage. Results – Drug expenses rose with increasing severity and duration of the disease. This increase differed somewhat between the two countries. Mean drug costs per day and patient in the German group was Euro 5.78 while it was Euro 3.92 in the Norwegian group. A higher proportion of the German patients were treated with two or more drugs, and the switch from mono‐ to multi‐drug therapy was done earlier in the course of the disease. Dopamine agonists caused 44% of total drug costs in both countries. Conclusion – Different management strategies of PD have a great impact on drug costs. Surveillance of prescription habits and careful cost/benefit analyses are therefore important.
Url:
DOI: 10.1111/j.1600-0404.2005.00574.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Drug costs for patients with Parkinson's disease in two different European countries</title><author><name sortKey="Vossius, C" sort="Vossius, C" uniqKey="Vossius C" first="C." last="Vossius">C. Vossius</name></author><author><name sortKey="Gjerstad, M" sort="Gjerstad, M" uniqKey="Gjerstad M" first="M." last="Gjerstad">M. Gjerstad</name></author><author><name sortKey="Baas, H" sort="Baas, H" uniqKey="Baas H" first="H." last="Baas">H. Baas</name></author><author><name sortKey="Larsen, J P" sort="Larsen, J P" uniqKey="Larsen J" first="J. P." last="Larsen">J. P. Larsen</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:044E9584A824B4E8816030AC59390DA3445CE972</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1111/j.1600-0404.2005.00574.x</idno><idno type="url">https://api.istex.fr/document/044E9584A824B4E8816030AC59390DA3445CE972/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002B27</idno><idno type="wicri:Area/Main/Curation">002762</idno><idno type="wicri:Area/Main/Exploration">001318</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Drug costs for patients with Parkinson's disease in two different European countries</title><author><name sortKey="Vossius, C" sort="Vossius, C" uniqKey="Vossius C" first="C." last="Vossius">C. Vossius</name><affiliation wicri:level="1"><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Neurology, Stavanger University Hospital, Stavanger</wicri:regionArea><wicri:noRegion>Stavanger</wicri:noRegion></affiliation></author><author><name sortKey="Gjerstad, M" sort="Gjerstad, M" uniqKey="Gjerstad M" first="M." last="Gjerstad">M. Gjerstad</name><affiliation wicri:level="1"><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Neurology, Stavanger University Hospital, Stavanger</wicri:regionArea><wicri:noRegion>Stavanger</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Norvège</country><wicri:regionArea>The Norwegian Centre for Movement Disorders, Stavanger</wicri:regionArea><wicri:noRegion>Stavanger</wicri:noRegion></affiliation></author><author><name sortKey="Baas, H" sort="Baas, H" uniqKey="Baas H" first="H." last="Baas">H. Baas</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Stadtkrankenhaus Hanau, Hanau</wicri:regionArea><wicri:noRegion>Hanau</wicri:noRegion><wicri:noRegion>Hanau</wicri:noRegion></affiliation></author><author><name sortKey="Larsen, J P" sort="Larsen, J P" uniqKey="Larsen J" first="J. P." last="Larsen">J. P. Larsen</name><affiliation wicri:level="1"><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Neurology, Stavanger University Hospital, Stavanger</wicri:regionArea><wicri:noRegion>Stavanger</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Norvège</country><wicri:regionArea>The Norwegian Centre for Movement Disorders, Stavanger</wicri:regionArea><wicri:noRegion>Stavanger</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Neurologica Scandinavica</title><idno type="ISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2006-04">2006-04</date><biblScope unit="volume">113</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="228">228</biblScope><biblScope unit="page" to="232">232</biblScope></imprint><idno type="ISSN">0001-6314</idno></series><idno type="istex">044E9584A824B4E8816030AC59390DA3445CE972</idno><idno type="DOI">10.1111/j.1600-0404.2005.00574.x</idno><idno type="ArticleID">ANE574</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-6314</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>cost analysis</term><term>dopamine agonists</term><term>drug costs</term><term>health economics</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objective – To examine factors that influence drug costs in patients with Parkinson's disease (PD) and to compare the costs in two different countries. Methods – We examined drug costs among 438 patients with PD (286 from Germany and 152 from Norway) and collected information on the patients’ age, medication, disease duration, and Hoehn & Yahr stage. Results – Drug expenses rose with increasing severity and duration of the disease. This increase differed somewhat between the two countries. Mean drug costs per day and patient in the German group was Euro 5.78 while it was Euro 3.92 in the Norwegian group. A higher proportion of the German patients were treated with two or more drugs, and the switch from mono‐ to multi‐drug therapy was done earlier in the course of the disease. Dopamine agonists caused 44% of total drug costs in both countries. Conclusion – Different management strategies of PD have a great impact on drug costs. Surveillance of prescription habits and careful cost/benefit analyses are therefore important.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Norvège</li></country></list><tree><country name="Norvège"><noRegion><name sortKey="Vossius, C" sort="Vossius, C" uniqKey="Vossius C" first="C." last="Vossius">C. Vossius</name></noRegion><name sortKey="Gjerstad, M" sort="Gjerstad, M" uniqKey="Gjerstad M" first="M." last="Gjerstad">M. Gjerstad</name><name sortKey="Gjerstad, M" sort="Gjerstad, M" uniqKey="Gjerstad M" first="M." last="Gjerstad">M. Gjerstad</name><name sortKey="Larsen, J P" sort="Larsen, J P" uniqKey="Larsen J" first="J. P." last="Larsen">J. P. Larsen</name><name sortKey="Larsen, J P" sort="Larsen, J P" uniqKey="Larsen J" first="J. P." last="Larsen">J. P. Larsen</name></country><country name="Allemagne"><noRegion><name sortKey="Baas, H" sort="Baas, H" uniqKey="Baas H" first="H." last="Baas">H. Baas</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001318 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001318 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:044E9584A824B4E8816030AC59390DA3445CE972
|texte= Drug costs for patients with Parkinson's disease in two different European countries
}}
| This area was generated with Dilib version V0.6.23. |  |